A moderate amount of a peptide-enhanced cancer drug goes a long way in treating breast cancers that metastasize […]

At the time of writing (24 January 2022), unvaccinated NHS workers in England have only until 3 February […]

It’s often too much for parents to absorb, especially when they’re sleep deprived and stressed. A smartphone app […]

By adapting techniques from the domain of artificial intelligence, such as deep learning, cognitive scientists from Osnabrück will […]

A problem with the reference list in this article by Richard Powell and colleagues (BMJ 2022;376:e065574; doi:10.1136/bmj-2021-065574) led […]

The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to […]

Beckley Psytech leads a new project focused on addressing  psychiatric and neurological conditions through the use of psychedelic medicines.

BDSI readies liquid migraine medicine launch but stays away from ‘broad blast’ marketing campaign sharon.coey Mon, 01/24/2022 – […]

AbbVie’s Skyrizi nabs psoriatic arthritis nod, its second, shortly after Rinvoq fkansteiner Mon, 01/24/2022 – 09:03

With omicron on the prowl, FDA extends inspection pause into February fkansteiner Mon, 01/24/2022 – 10:01